Effect of brimonidine tartrate on ocular hemodynamic measurements

Archives of Ophthalmology

Volumn 116, Issue 12, 1998, Pages 1591-1594

  Lachkar, Yves ^a   Migdal, Clive ^a   Dhanjil, Surinda ^b  

^a WESTERN EYE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE;

ADULT; AGED; ARTICLE; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EYE BLOOD FLOW; HEMODYNAMICS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR HYPOTENSION; OPHTHALMIC ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032423097     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.12.1591     Document Type: Article

References (33)

1. Fechtner R, Weinreb R. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 1994;39:23-42.
2. David R, Spaéth GL, Clevenger CE, et al. Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty. Arch Ophthalmol. 1993;111:1387-1390.
3. Barnebey H, Robin A, Zimmerman T, et al. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty. Ophthalmology. 1993;100:1083-1088.
4. Greenfield DS, Liebmann JM, Ritch R. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment. J Glaucoma. 1997;6: 250-258.
5. Serdahl CL, Galustian J, Lewis RA. The effects of apraclonidine on conjunctival oxygen tension. Arch Ophthalmol. 1989;107:1777-1779.
6. Van Busrkik M. Replication of ciliary vasomotor effect with controlled intravascular corrosion casting. Trans Am Ophthalmol Soc. 1989;87:125-140.
7. Abrams DA, Robin AL, Pollack IP, deFaller JM, DeSantis L. The safety and efficacy of topical 1% ALO 2145 (P-aminoclonidine hydrochloride) in normal volunteers. Arch Ophthalmol. 1987;105:1205-1207.
8. Planiol T, Pourcelot L, Pettier JM, Degiovanni G. Etude de la circulation carotidienne par les méthodes ultrasonographiques et la thermographie. Rev Neurol. 1972;126:127-141.
9. Altman DG. Clinical trials. In: Practical Statistics for Medical Research. London, England: Chapman & Hall Ltd; 1991:467-471.
10. Harris A, Williamson TH, Martin B, et al. Test/retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels. J Glaucoma. 1995;4:281-286.
11. Burke J, Schwartz M. Preclinical evaluation of brimonidine. Surv Ophthalmol. 1996;41:9-18.
12. Torris CB, Gleason ML, Camras C, Yablonski M. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 1995;113: 1514-1517.
13. Grunwald JE. Effect of timolol maleate on the retinal circulation of human eyes with ocular hypertension. Invest Ophthalmol Vis Sci. 1990;31:521-526.
14. Koyama T, Matsuo N, Shimizu K, et al. Retinal circulation times in quantitative fluorescein angiography. Graefes Arch Clin Exp Ophthalmol. 1990;228: 442-446.
15. Cantor LB, Harris A, Wolf S, Sponsel W, Arend O. Measurement of superficial optic nerve head capillary blood velocities by scanning laser fluorescein angiography. J Glaucoma. 1994;3:S61-S64.
16. Riva CE, Grunwald JE, Sinclair SH. Laser Doppler measurement of relative blood velocity in the human optic nerve head. Invest Ophthalmol Vis Sci. 1982;22:241-248.
17. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Non-contact two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res. 1995;60:373-384.
18. Riva CE, Petrig B. Blue field entoptic phenomenon and blood velocity in the retinal capillaries. J Opt Soc Am A. 1980;70:1234-1238.
19. Langham ME, Farell RA, O'Brien V, Silver DM, Schilder P. Non-invasive measurement of pulsatile ocular blood flow in the human eye. In: Lambrou GN, Greve EL, eds. Ocular Blood Flow in Glaucoma. Berkeley, Calif: Kugler and Ghedini Publishers; 1989:93-101.
20. Butt Z, O'Brien C. Reproducibility of pulsatile ocular blood flow measurements. J Glaucoma. 1995;4:214-218.
21. Williamson TH, Harris A. Color Doppler ultrasound imaging of the eye and orbit. Surv Ophthalmol. 1996;40:255-267.
22. Dennis KJ, Dixon ED, Winsberg F, Ernest JT, Goldstick TK. Variability in measurement of central retinal artery velocity using color Doppler imaging. J Ultrasound Med. 1995;14:463-466.
23. Okubo H, Gherezghiher T, Koss MC. Long posterior ciliary arterial blood flow and systemic blood pressure. Invest Ophthalmol Vis Sci. 1992;33:48-54.
24. Yu DY, Alder VA, Su EM, et al. Agonist response to human isolated posterior ciliary artery. Invest Ophthalmol Vis Sci. 1992;33:48-54.
25. Orgul S, Bacon D, Van Buskirk E, Cioffi G. Optic nerve vasomotor effects of topical apraclonidine hydrochloride. Br J Ophthalmol. 1996;80:82-84.
26. Spada CS, Nieves AL, Burke JA, et al. Comparative effects of brimonidine, p-aminiclonidine and clonidine on arterail caliber in human retinal tissue. Invest Ophthalmol Vis Sci. 1995;36:1041.
27. Acheampong A, Shackelton M, Tang-Liu D. Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits. Drug Metab Dispos. 1995;23:708-712.
28. Chien DS, Richman J, Zolezio H, et al. Drug distribution of brimonidine in albino pigmented rabbit eyes. Pharm Res. 1992;S9:336.
29. Bhandari A, Orgul S, Bacon D, et al. Effect of brimonidine on optic nerve blood flow in rabbits. Invest Ophthalmol Vis Sci. 1997;S38:783.
30. Hoffman B, Lefkowitz R. Adrenergic receptor antagonists. In: Goodman R, Gilman E, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 5th ed. Ontario, Canada: McGraw-Hill Ryerson Ltd; 1991:221-223.
31. Angus JA, Cocks TM, Wright CE, et al. Endothelium-dependent responses in large arteries and in the microcirculation. In: Vanhoutte PM, ed. Relaxing and Contracting Factors. Totowa, NJ: Humana Press; 1988:361-387.
32. Bockman CS, Jeffries WB, Abel PW. Binding and functional characterizations of α-2 adrenergic receptor subtypes on pig vascular endothelium. J Pharmacol Exp Ther. 1993;267:1126-1133.
33. Norlund J, Pasquale LR, Robin AL, et al. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol. 1995;113: 77-83.